Infanrix penta

BIOLOGICAL2 trials

Sponsors

GlaxoSmithKline

Conditions

Acellular PertussisDiphtheriaHaemophilus Influenzae Type bHepatitis BNeisseria MeningitidisPoliomyelitisStreptococcus Pneumoniae VaccinesTetanus

Phase 3

Primary & Booster Study in Infants to Demonstrate Non-inferiority, Persistence & Immunogenicity of Hib-MenC Vaccine

CompletedNCT00327184

GlaxoSmithKlineHaemophilus Influenzae Type b, Neisseria Meningitidis

Start: 2006-04-30End: 2006-11-30Updated: 2016-10-07

Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines

CompletedNCT00463437

GlaxoSmithKlineAcellular Pertussis, Diphtheria, Hepatitis B +3

Start: 2007-04-25End: 2008-06-14Updated: 2020-01-02

Related Papers

Antibody persistence and immunologic memory in children vaccinated with 4 doses of pneumococcal conjugate vaccines: Results from 2 long-term follow-up studies

Human Vaccines & Immunotherapeutics2016-10-137 citations

A combined Haemophilus influenzae type B Neisseria meningitidis serogroup C tetanus toxoid conjugate vaccine is immunogenic and well-tolerated when coadministered with diphtheria, tetanus, acellular pertussis hepatitis B-inactivated poliovirus at 3, 5 and 11 months of age: results of an open, randomized, controlled study.

2013-05-017 citations